Late‐Stage Modification of Halotryptophan‐Containing Peptides Via Negishi Cross‐Coupling
Chemistry – A European Journal · 11.09.2026 · 32 (34)
DOI: 10.1002/chem.71177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 25.05.2026. Verfasst von Laura Cerveson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Organic and Bioorganic Chemistry, Bielefeld University, Bielefeld, Germany. Hauptthemen laut MEDLINE: Tryptophan, Peptides, Oligopeptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Late‐stage functionalization of peptides provides powerful opportunities for the rapid diversification of bioactive sequences. Among the available strategies, Negishi cross‐coupling represents a versatile and orthogonal method for the installation of alkyl substituents under mild conditions. We describe the applicability of Negishi cross‐coupling to increasingly complex bromotryptophan‐containing peptides. While conditions effective for bromo‐ l ‐tryptophan proved unsuitable for peptide substrates, leading to incomplete conversion and pronounced debromination, systematic optimization enabled efficient cross‐coupling of the model tripeptide Ac‐Ala‐Trp(6‐Br)‐Gly‐NH 2 . The optimized protocol afforded good to excellent conversions and isolated yields while maintaining operational simplicity. A key limitation arising from peptide solubility was addressed through the yet underexplored use of DMSO and DMSO/DMF solvent systems in Negishi cross‐couplings, which enabled efficient reaction of peptides bearing either 6‐ or 7‐bromo‐ l ‐tryptophan as well as unprotected residues such as aspartic acid and serine. Application to more complex pentapeptides revealed solvent‐dependent reactivity: poor solubility in DMF resulted in reduced conversion and increased debromination, whereas DMSO‐containing solvent systems significantly improved both solubility and catalytic performance. These results demonstrate that Negishi cross‐coupling can be adapted for the late‐stage functionalization of bromotryptophan‐containing peptides with functional group tolerance in structurally complex peptide substrates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Organic and Bioorganic Chemistry, Bielefeld University, Bielefeld, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Cerveson, L., Heldt, M. J., & Sewald, N. (2026). Late‐Stage Modification of Halotryptophan‐Containing Peptides Via Negishi Cross‐Coupling. Chemistry – A European Journal, 32(34). https://doi.org/10.1002/chem.71177
Vancouver
Cerveson L, Heldt MJ, Sewald N. Late‐Stage Modification of Halotryptophan‐Containing Peptides Via Negishi Cross‐Coupling. Chemistry – A European Journal. 2026;32(34). doi:10.1002/chem.71177
BibTeX
@article{Cerveson2026,
author = {Cerveson, Laura and Heldt, Marcel-Jannik and Sewald, Norbert},
title = {Late‐Stage Modification of Halotryptophan‐Containing Peptides Via Negishi Cross‐Coupling},
journal = {Chemistry – A European Journal},
year = {2026},
volume = {32},
number = {34},
doi = {10.1002/chem.71177}
}
EUVIMED